Industry-sponsored research - PubMed
Review
Industry-sponsored research
Kanu Okike et al. Injury. 2008 Jun.
Abstract
Financial conflicts of interest are exceedingly common in biomedical research. Investigators with conflicts of interest are more likely to arrive at positive conclusions, perhaps as a result of biased study design, industry suppression of negative results, preferential funding by industry of projects that are likely to succeed, or biased interpretation of results on the part of investigators. Government and professional organisations have proposed guidelines for managing conflicts of interest, but in practice it is the policies of universities and medical journals that direct the actions of investigators. Academic researchers and the media have expressed concern about the influence of industry sponsorship on biomedical research, while industry is increasingly turning to private entities (such as contract research organisations) to conduct clinical trials. Research participants appear less concerned with conflicts of interest in biomedical research, perhaps due to a faith that such conflicts are being appropriately managed by institutions. After reviewing the literature, we provide recommendations for the ethical conduct of biomedical research in the presence of financial conflicts of interest.
Similar articles
-
Tereskerz PM, Moreno J. Tereskerz PM, et al. Account Res. 2005 Apr-Jun;12(2):139-55. doi: 10.1080/08989620590957229. Account Res. 2005. PMID: 16220626
-
Jagsi R, Sheets N, Jankovic A, Motomura AR, Amarnath S, Ubel PA. Jagsi R, et al. Cancer. 2009 Jun 15;115(12):2783-91. doi: 10.1002/cncr.24315. Cancer. 2009. PMID: 19434666
-
Extent and impact of industry sponsorship conflicts of interest in dermatology research.
Perlis CS, Harwood M, Perlis RH. Perlis CS, et al. J Am Acad Dermatol. 2005 Jun;52(6):967-71. doi: 10.1016/j.jaad.2005.01.020. J Am Acad Dermatol. 2005. PMID: 15928613 Review.
-
[Medicine: conflicts of interest in research].
Fallena-Zonana M, Kraus-Weisman A. Fallena-Zonana M, et al. Rev Invest Clin. 2003 May-Jun;55(3):339-46. Rev Invest Clin. 2003. PMID: 14515679 Review. Spanish.
Cited by
-
Pitak-Arnnop P, Pausch NC, Dhanuthai K, Sappayatosok K, Ngamwannagul P, Bauer U, Sader R, Rapidis AD, Hervé C, Hemprich A. Pitak-Arnnop P, et al. Eplasty. 2010 May 21;10:e36. Eplasty. 2010. PMID: 20505849 Free PMC article.
-
Moskowitz JM, Myung SK, Choi YJ, Hong YC. Moskowitz JM, et al. Int J Environ Res Public Health. 2021 May 24;18(11):5581. doi: 10.3390/ijerph18115581. Int J Environ Res Public Health. 2021. PMID: 34073653 Free PMC article.
-
Review and Analysis of Publication Trends over Three Decades in Three High Impact Medicine Journals.
Ivanov A, Kaczkowska BA, Khan SA, Ho J, Tavakol M, Prasad A, Bhumireddy G, Beall AF, Klem I, Mehta P, Briggs WM, Sacchi TJ, Heitner JF. Ivanov A, et al. PLoS One. 2017 Jan 20;12(1):e0170056. doi: 10.1371/journal.pone.0170056. eCollection 2017. PLoS One. 2017. PMID: 28107475 Free PMC article.
-
Johanning E, Stillo M, Landsbergis P. Johanning E, et al. Ind Health. 2022 Jun 1;60(3):288-292. doi: 10.2486/indhealth.2021-0125. Epub 2021 Oct 25. Ind Health. 2022. PMID: 34690252 Free PMC article. No abstract available.
-
Atallah D, Moubarak M, El Kassis N, Abboud S. Atallah D, et al. Trials. 2018 Jan 11;19(1):27. doi: 10.1186/s13063-017-2397-2. Trials. 2018. PMID: 29325585 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources